当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Immunotherapy: CAR T cell therapy efficacious against B-ALL across age groups
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-02-20 , DOI: 10.1038/nrclinonc.2018.32 Peter Sidaway
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-02-20 , DOI: 10.1038/nrclinonc.2018.32 Peter Sidaway
Immunotherapy: CAR T cell therapy efficacious against B-ALL across age groups
中文翻译:
免疫疗法:CAR T细胞疗法可有效抵抗所有年龄段的B-ALL
免疫疗法:CAR T细胞疗法可有效抵抗所有年龄段的B-ALL
更新日期:2018-02-21
Immunotherapy: CAR T cell therapy efficacious against B-ALL across age groups, Published online: 20 February 2018; doi:10.1038/nrclinonc.2018.32
Immunotherapy: CAR T cell therapy efficacious against B-ALL across age groups中文翻译:
免疫疗法:CAR T细胞疗法可有效抵抗所有年龄段的B-ALL
免疫疗法:CAR T细胞疗法可有效抵抗所有年龄段的B-ALL
免疫疗法:跨年龄段的B-ALL有效的CAR T细胞疗法,在线发布:2018年2月20日; doi:10.1038 / nrclinonc.2018.32
免疫疗法:CAR T细胞疗法可有效抵抗所有年龄段的B-ALL